Cargando…
A potent MAPK13–14 inhibitor prevents airway inflammation and mucus production
Common respiratory diseases continue to represent a major public health problem, and much of the morbidity and mortality is due to airway inflammation and mucus production. Previous studies indicated a role for mitogen-activated protein kinase 14 (MAPK14) in this type of disease, but clinical trials...
Autores principales: | Keeler, Shamus P., Wu, Kangyun, Zhang, Yong, Mao, Dailing, Li, Ming, Iberg, Courtney A., Austin, Stephen R., Glaser, Samuel A., Yantis, Jennifer, Podgorny, Stephanie, Brody, Steven L., Chartock, Joshua R., Han, Zhenfu, Byers, Derek E., Romero, Arthur G., Holtzman, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246002/ https://www.ncbi.nlm.nih.gov/pubmed/37292761 http://dx.doi.org/10.1101/2023.05.26.542451 |
Ejemplares similares
-
Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming
por: Wu, Kangyun, et al.
Publicado: (2022) -
Lung Remodeling Regions in Long-Term Coronavirus Disease 2019 Feature Basal Epithelial Cell Reprogramming
por: Wu, Kangyun, et al.
Publicado: (2023) -
Strategies for measuring airway mucus and mucins
por: Atanasova, Kalina R., et al.
Publicado: (2019) -
Airway Mucus Dysfunction in COVID-19
por: Dickey, Burton F., et al.
Publicado: (2022) -
An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease
por: Martin, Ryan A., et al.
Publicado: (2022)